Fresenius SE & Co KGaA FRE-DE:XETRA

*Data is delayed | EUR
Last | 5:35 PM CEST
41.35quote price arrow up+0.24 (+0.57%)
Volume
627,563
52 week range
31.03 - 47.59
Loading...
  • Open41.48
  • Day High41.78
  • Day Low41.26
  • Prev Close41.12
  • 52 Week High47.59
  • 52 Week High Date08/18/21
  • 52 Week Low31.03
  • 52 Week Low Date10/30/20

Key Stats

  • Market Cap26,869.58M
  • Shares Out558.04M
  • 10 Day Average Volume1.17M
  • Dividend0.88
  • Dividend Yield2.13%
  • Beta-
  • YTD % Change9.29

KEY STATS

  • Open41.48
  • Day High41.78
  • Day Low41.26
  • Prev Close41.12
  • 52 Week High47.59
  • 52 Week High Date08/18/21
  • 52 Week Low31.03
  • 52 Week Low Date10/30/20
  • Market Cap26,869.58M
  • Shares Out558.04M
  • 10 Day Average Volume1.17M
  • Dividend0.88
  • Dividend Yield2.13%
  • Beta-
  • YTD % Change9.29

RATIOS/PROFITABILITY

  • EPS (TTM)3.13
  • P/E (TTM)13.21
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date05/25/2021
  • Div Amount0.88
  • Split Date-
  • Split Factor-

Latest On Fresenius SE & Co KGaA

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Fresenius SE & Co KGaA is a Germany-based healthcare group. It operates through four business segments. Fresenius Medical Care runs a global network of dialysis clinics, providing treatment for patients with chronic kidney failure. It also offers dialyzers, dialysis machines and renal pharmaceuticals. Fresenius Kabi specializes in intravenously administered generic drugs (IV drugs), clinical nutrition and infusion therapies. It also supplies hospitals with medical devices and...
Rachel Empey
Chief Financial Officer
Address
Else-Kroener-Str. 1
Bad Homburg Vor Der Hohe
61352
Germany